Table 2.
Clinical characteristics, meditation history, and expectancy
| Variable | Mindfulness | Control | Statistic | P |
|---|---|---|---|---|
| Cancer type | Χ2(15) = 12.52 | .639 | ||
| Bone/soft tissue | 4 (6.0%) | 2 (3.4%) | ||
| Brain | 2 (3.0%) | 2 (3.4%) | ||
| Breast | 23 (34.3%) | 20 (34.5%) | ||
| Cervical | 1 (1.5%) | 0 (0.0%) | ||
| Colorectal | 3 (4.5%) | 2 (3.4%) | ||
| Head and neck | 0 (0.0%) | 2 (3.4%) | ||
| Leukemia | 4 (6.0%) | 4 (6.8%) | ||
| Liver | 1 (1.5%) | 0 (0.0%) | ||
| Lung | 1 (1.5%) | 1 (1.7%) | ||
| Lymphoma | 15 (22.4%) | 17 (28.8%) | ||
| Melanoma | 4 (6.0%) | 2 (3.4%) | ||
| Ovarian | 1 (1.5%) | 0 (0.0%) | ||
| Stomach and esophageal | 0 (0.0%) | 1 (1.7%) | ||
| Testicular | 1 (1.5%) | 2 (3.4%) | ||
| Thyroid and endocrine | 0 (0.0%) | 2 (3.4%) | ||
| Other | 7 (10.4%) | 2 (3.4%) | ||
| Meditation history | Χ2(2) = 5.23 | .073 | ||
| Never | 26 (38.8%) | 19 (32.2%) | ||
| Occasionally | 25 (37.3%) | 33 (55.9%) | ||
| Regularly | 16 (23.9%) | 7 (11.9%) | ||
| Expectancy | 0.14 ± 2.91 | −0.15 ± 2.42 | t(123) = 0.60 | .553 |
| Credibility | −0.02 ± 2.57 | 0.03 ± 2.49 | t(123) = −0.12 | .908 |
Note:
*
P < .05
**
P < .01.